AF
ONCY

Aviso Financial’s Oncolytics Biotech ONCY Stock Holding History

Aviso Financial’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.11K Buy
1,304
+1,252
+2,408% +$1.25K ﹤0.01% 323
2025
Q4 		$45 Hold
52
– – ﹤0.01% 343
2025
Q3 		$72 Hold
52
– – ﹤0.01% 344
2025
Q2 		$39 Hold
52
– – ﹤0.01% 348
2025
Q1 		$28 Hold
52
– – ﹤0.01% 349
2024
Q4 		$48 Hold
52
– – ﹤0.01% 355
2024
Q3 		$46 Sell
52
-4
-7% -$4 ﹤0.01% 357
2024
Q2 		$55 Buy
+56
New +$61 ﹤0.01% 348

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Aviso Financial's ONCY Position: Q1 2026 in Review

Aviso Financial increased its Oncolytics Biotech (ONCY) stake by 2,408% in Q1 2026, buying an estimated $1.25K and bringing the position to 1,304 shares worth $1.11K. The position accounts for ﹤0.01% of the portfolio, ranked #323.

Aviso Financial first reported a position in ONCY in Q2 2024 and has held it in 8 quarters since. 59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.

  • Aviso Financial held 1,304 shares of Oncolytics Biotech worth $1.11K as of Q1 2026.
  • Aviso Financial bought 1,252 Oncolytics Biotech shares in Q1 2026, an estimated $1.25K.
  • Oncolytics Biotech made up ﹤0.01% of Aviso Financial's portfolio in Q1 2026, its #323 holding.
  • Aviso Financial first reported a position in Oncolytics Biotech in Q2 2024 and has held it in 8 quarters since.
  • 59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.

Based on Aviso Financial's 13F filing for Q1 2026, filed 14 May 2026.